STING agonists drive intrinsic type I interferon responses in monocytes for optimal anti-tumor immunity

被引：0
|
作者：
Yu, Tianning
Girard, Melanie
Watts, Tania H.
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2023年 / 11卷 / 12期
关键词：
D O I：
10.1158/2326-6074.TUMIMM23-A012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A012
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Tumor- intrinsic cGAS-STING activation promotes anti-tumor inflammatory response in osteosarcoma
    Young, Elizabeth Betsy Peale
    Johnson, Christine
    Lee, Alex G.
    Sweet-Cordero, Eric Alejandro
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Environmentally responsive hydrogel promotes vascular normalization to enhance STING anti-tumor immunity
    Wang, Duo
    Deng, Xiujiao
    Wang, Jinghao
    Che, Shuang
    Ma, Xiaocong
    Zhang, Siqi
    Dong, Qiu
    Huang, Cuiqing
    Chen, Jifeng
    Shi, Changzheng
    Zhang, Ming-Rong
    Hu, Kuan
    Luo, Liangping
    Xiao, Zeyu
    JOURNAL OF CONTROLLED RELEASE, 2024, 372 : 403 - 416
  • [33] Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation
    Temizoz, Burcu
    Hioki, Kou
    Kobari, Shingo
    Jounai, Nao
    Kusakabe, Takato
    Lee, Michelle S. J.
    Coban, Cevayir
    Kuroda, Etsushi
    Ishii, Ken J.
    INTERNATIONAL IMMUNOLOGY, 2022, 34 (07) : 353 - 364
  • [34] Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer
    Liao, Yuanyu
    Yang, Rui
    Wang, Bojun
    Ruan, Yuli
    Cui, Luying
    Yang, Jiani
    Yu, Xuefan
    Han, Shuling
    Yao, Yuanfei
    Luan, Xindi
    Li, Yingjue
    Shi, Mengde
    Li, Shuijie
    Liu, Chao
    Zhang, Yanqiao
    ONCOGENE, 2024, : 944 - 957
  • [35] RORγ agonists regulate immune checkpoint receptors to enhance anti-tumor immunity
    Hu, Xiao
    Liu, Xikui
    Moisan, Jacques
    Paulos, Chrystal
    Wang, Yahong
    Spooner, Chauncey
    Lesch, Charles
    Morgan, Rodney
    Mertz, David
    Bousley, Dick
    Taylor, Clarke
    Van Huis, Chad
    Skalitzky, Don
    Aicher, Thomas
    Toogood, Peter
    Carter, Laura
    CANCER RESEARCH, 2016, 76
  • [36] Tumor cell-intrinsic STING pathway activation leads to robust induction of Type III Interferons and contributes to the anti-tumor activity elicited by STING agonism.
    Cetinbas, Naniye Malli
    Monnell, Travis
    Catcott, Kalli
    Lee, Winnie
    Shaw, Pamela
    Slocum, Kelly
    Avocetien, Kenneth
    Bentley, Keith
    Clardy, Susan
    Jones, Brian
    Kelleher, Eoin
    Mosher, Rebecca
    Thomas, Joshua D.
    Toader, Dorin
    Duvall, Jeremy
    Bukhalid, Raghida A.
    Damelin, Marc
    Lowinger, Timothy B.
    CANCER RESEARCH, 2021, 81 (13)
  • [37] Co-delivery of synergistic immune agonists via systemic nanoparticles for interferon β-driven anti-tumor immunity and prevention of metastasis
    Atukorale, Prabhani
    Hoimes, Chris
    Karathanasis, Efstathios
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [38] Localized Intra-Cavitary Therapy to Drive Systemic Anti-Tumor Immunity
    Donnenberg, Vera S.
    Wagner, Patrick L.
    Luketich, James D.
    Bartlett, David L.
    Donnenberg, Albert D.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [39] TUMOR TARGETED TYPE I INTERFERON ENGAGES DENDRITIC CELLS TO ENHANCE THE ANTI-TUMOR RESPONSE TO RADIOTHERAPY.
    Bugno, J.
    Wang, L.
    Fu, Y.
    Weichselbaum, R.
    Liang, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S11 - S11
  • [40] Versican proteolytic fragments (matrikines) synergize with STING agonists to elicit robust anti-tumor CD8+T cell responses
    Papadas, Athanasios
    Flietner, Evan
    Morrow, Zachary
    Wiesner, Joshua
    Cicala, Alexander
    Pagenkopf, Adam
    Hope, Chelsea
    Emmerich, Philip
    Deming, Dustin
    Zhang, Jing
    Hematti, Peiman
    Callander, Natalie
    Rakhmilevich, Alexander
    Otto, Mario
    Capitini, Christian
    Asimakopoulos, Fotis
    CANCER RESEARCH, 2020, 80 (16)
12345